Ali Ahmed, Zayed Hany, Wilkins Jason, Wyatt Hilary, Rashid Hisham
Department of Vascular Surgery, King's College Hospital, Denmark Hill, London, United Kingdom.
Vasc Endovascular Surg. 2009 Jun-Jul;43(3):280-3. doi: 10.1177/1538574408329270. Epub 2009 Jan 21.
Port-a-cath insertion, for long-term intravenous antibiotic therapy, is an ideal solution for patient with cystic fibrosis. However, indwelling lines are liable to many complications including catheter thrombosis especially in patients having cystic fibrosis with hypercoagulable state.
An endovascular technique for insertion of a port-a-cath in a patient having cystic fibrosis with occluded superior vena cava is reported. The technique is described in detail. In addition, a review of literature for the various methods of saving a failed central venous access in these patients was performed.
The line was successfully inserted and remained patent without need of any further intervention for 20 months.
In this report, several endovascular skills were used for central venous access salvage that can be used in similar situations with chronic superior vena cava occlusion, which may not be suitable for thrombolysis or stenting.
对于患有囊性纤维化的患者,植入输液港进行长期静脉抗生素治疗是一种理想的解决方案。然而,留置导管容易引发多种并发症,包括导管血栓形成,尤其是在患有囊性纤维化且处于高凝状态的患者中。
报告了一种为患有囊性纤维化且上腔静脉闭塞的患者植入输液港的血管内技术。详细描述了该技术。此外,还对这些患者挽救失败的中心静脉通路的各种方法进行了文献综述。
导管成功植入,20个月来保持通畅,无需进一步干预。
在本报告中,使用了多种血管内技术来挽救中心静脉通路,这些技术可用于慢性上腔静脉闭塞的类似情况,而这些情况可能不适合溶栓或支架置入术。